• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diabetes Obes Metab . Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study

tetano

Editor, Senior Moderator
Diabetes Obes Metab


. 2020 Oct 14.
doi: 10.1111/dom.14228. Online ahead of print.
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: results from the CORONADO study


Sarra Smati[SUP] 1 [/SUP], Blandine Tramunt[SUP] 2 [/SUP], Matthieu Wargny[SUP] 1 3 [/SUP], Cyrielle Caussy[SUP] 4 5 [/SUP], B?n?dicte Gaborit[SUP] 6 [/SUP], Camille Vatier[SUP] 7 8 [/SUP], Bruno Verg?s[SUP] 9 [/SUP], Deborah Ancelle[SUP] 10 [/SUP], Coralie Amadou[SUP] 11 [/SUP], Leila Ait Bachir[SUP] 12 [/SUP], Olivier Bourron[SUP] 13 [/SUP], Christine Coffin-Boutreux[SUP] 14 [/SUP], Sara Barraud[SUP] 15 [/SUP], Anne Dorange[SUP] 16 [/SUP], B?n?dicte Fremy[SUP] 17 [/SUP], Jean-Fran?ois Gautier[SUP] 18 19 [/SUP], Natacha Germain[SUP] 20 [/SUP], Etienne Larger[SUP] 21 [/SUP], St?phanie Laugier-Robiolle[SUP] 22 [/SUP], Laurent Meyer[SUP] 23 [/SUP], Arnaud Monier[SUP] 24 [/SUP], Isabelle Moura[SUP] 25 [/SUP], Louis Potier[SUP] 26 [/SUP], Nadia Sabbah[SUP] 27 28 [/SUP], Dominique Seret-B?gu?[SUP] 29 [/SUP], Patrice Winiszewski[SUP] 30 [/SUP], Matthieu Pichelin[SUP] 1 [/SUP], Pierre-Jean Saulnier[SUP] 31 [/SUP], Samy Hadjadj[SUP] 1 [/SUP], Bertrand Cariou[SUP] 1 [/SUP], Pierre Gourdy[SUP] 2 [/SUP], CORONADO investigators



Affiliations

Abstract

Aims: Obesity and diabetes have been identified as comorbidities frequently associated with severe forms of COVID-19. Here, we specifically assessed the relationship between BMI classes and early COVID-19 prognosis in inpatients with type 2 diabetes (T2D).
Methods: From the CORONAvirus-SARS-CoV-2 and Diabetes Outcomes (CORONADO) study, we conducted an analysis in patients with T2D categorized in four BMI subgroups according to the World Health Organization classification. Clinical characteristics and COVID-19-related outcomes (i.e. intubation for mechanical ventilation [IMV], death and discharge by day 7 [D7]) were analyzed according to BMI status.
Results: Among 1,965 patients with T2D, 434 (22.1%) normal-weight (18.5-24.9 kg/m?, reference group), 726 (36.9%) overweight (25-29.9 kg/m?) and 805 (41.0%) obese subjects were analyzed, including 491 (25.0%) with class I obesity (30-34.9 kg/m?) and 314 (16.0%) with class II/III obesity (≥ 35 kg/m[SUP]2[/SUP] ). In a multivariable-adjusted model, the primary outcome (i.e. IMV and/or death by D7) was significantly associated with overweight (OR 1.65 [1.05-2.59]), class I (OR 1.93 [1.19-3.14]) and class II/III obesity (OR 1.98 [1.11-3.52]). After multivariable adjustment, primary outcome by D7 was significantly associated with obesity in patients under 75 years, while such association was no longer found in those over 75 years.
Conclusions: Overweight and obesity are associated with poor early prognosis in patients with T2D hospitalized for COVID-19. Importantly, the deleterious impact of obesity on COVID-19 prognosis was no longer observed in the elderly, highlighting the need for a specific management in this specific population. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; elderly; mechanical ventilation; obesity; prognosis; type 2 diabetes.
 
Back
Top Bottom